Generate a tailored SOP for Dr. Ted Getz. Improve your application with a focused, well-structured draft.
Ted Getz is a Clinical Fellow at Yale School of Medicine, specializing in hematology and oncology. He graduated from Case Western Reserve University School of Medicine in 2020 and completed his residency in Internal Medicine at Weill Cornell/New York Presbyterian Hospital. His clinical research interests are primarily focused on myeloid malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Dr. Getz is actively involved in outcomes research and clinical trial methodology, contributing to the development of institutional and multi-institutional registries aimed at advancing care for patients with hematologic cancers. He is a member of several professional organizations, including the American Society of Clinical Oncology and the European Hematology Association. Dr. Getz has also served as a reviewer for the journal Therapeutic Advances in Hematology and contributes to various professional activities within the hematology community.
Yale Comprehensive Cancer Center • New Haven, Connecticut
Clinical Fellow in hematology and oncology, focusing on myeloid malignancies and related clinical research.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.